Autopsy report · NCT03312400

Low-Dose Danazol for the Treatment of Telomere Related Diseases

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Study was stopped due to poor accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 months before it started.
Ran for about 7 years 9 months before it stopped.
18 participants enrolled.
Results were posted on the registry 1 year after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sponsor type: US National Institutes of Health
Conditions: Telomere Disease
Interventions: Danazol
Participants: 18
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.